Ki16198, CAS 355025-13-7

Product Description: Ki16198 is a potent and orally active LPA receptor antagonist, the methyl ester of Ki16425 (HY-13285). Ki16198 inhibits LPA1 and LPA3-induced inositol phosphate production with?Ki?values of 0.34 μM and 0.93 μM, respectively. Ki16198 is effective for pancreatic cancer tumorigenesis and metastasis in vivo[1].

Applications: Cancer-programmed cell death

Formula: C24H25ClN2O5S

References: [1]Mayumi Komachi, et al. Orally active lysophosphatidic acid receptor antagonist attenuates pancreatic cancer invasion and metastasis in vivo. Cancer Sci. 2012 Jun;103(6):1099-104.

CAS Number: 355025-13-7

Molecular Weight: 488.98

Compound Purity: 98.04

Research Area: Cancer

Solubility: DMSO : 100 mg/mL (ultrasonic)

Target: LPL Receptor

• Artikelnummer: MEXHY-18641-10.1
• Hersteller: MedChemExpress
• Hersteller Artikelnummer: HY-18641-10.1
• Verpackungseinheit: 10 mM/1 ml
• Mengeneinheit: STK